Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Fultz Paul GDirector | Grant or award | A | $23K 518 sh | Jul 2, 2026 |
| 9 | Blizard JeffreyDirector | Grant or award | A | — 5,524 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 9 | Bonanni Mark EmilioEVP, CRO, Commercial | Option exercise | M | — 4,507 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 9 | Dick BarryDirector | Option exercise | M | — 15.8K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 9 | Daley PamelaDirector | Grant or award | A | — 30 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 9 | Malyala VikranthSVP, Chief Business Officer | Option exercise | M | — 4,600 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 9 | Nasser Amin H.Director | Grant or award | A | — 30 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 9 | Petty JoshuaEVP & General Counsel | Tax withholding | F | $15K 244 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 9 | Malyala VikranthSVP, Chief Business Officer | Option exercise | M | — 507 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 9 | Bonanni Mark EmilioEVP, CRO, Commercial | Grant or award | A | — 164 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 9 | Angel ScottDirector | Option exercise | M | — 5,383 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 8 | Bawel David BenjaminSVP & CHIEF ACCOUNTING OFFICER | Other acquisition or disposition | J | $8,256 515 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 7 | Ribeiro RamiroChief Medical Officer | Option exercise · 10b5-1 plan | M | $20K 2,438 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 6 | Finn Mark StevenDirector | Option exercise | M | — 2,344 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 5 | O'Hara David MarkDirector | Grant or award | A | $19K 4,464 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 5 | O'Hara David MarkDirector | Grant or award | A | $13K 3,052 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 5 | Cordella Richard James JRDirector | Grant or award | A | — 2,652 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 5 | Famularo Adam FrancisDirector | Grant or award | A | — 2,652 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 5 | Doukeris Michel DDirector | Grant or award | A | — 130 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 5 | Narayanan ArunChief Executive Officer | Option exercise | M | — 8,125 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 5 | Liu Teyin MDirector | Grant or award | A | — 27 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 5 | Novack Jeffrey AdamSecretary and General Counsel | Tax withholding | F | $29K 997 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 4 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | Open-market sale · 10b5-1 plan | SELL | $290K 3,500 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 4 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | Open-market sale · 10b5-1 plan | SELL | $327K 3,900 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 4 | Katz ZacharyCLO and Head of Global Affairs | Open-market sale · 10b5-1 plan | SELL | $208K 12.8K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 2 | Graham-Cumming JohnDirector | Grant or award | A | — 842 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 2 | Finn Mark StevenDirector | Option exercise | M | — 2,344 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 2 | Finn Mark StevenDirector | Grant or award | A | — 2,782 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 0 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | Derivative conversion · 10b5-1 plan | C | — 83.3K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 0 | Ribeiro RamiroChief Medical Officer | Option exercise · 10b5-1 plan | M | $20K 2,437 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 0 | Ribeiro RamiroChief Medical Officer | Option exercise · 10b5-1 plan | M | — 2,438 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 0 | Ribeiro RamiroChief Medical Officer | Option exercise · 10b5-1 plan | M | — 2,437 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 0 | Schubach Sarah ElizabethChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $35K 1,305 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 0 | Whalen Thomas GerardDirector | Grant or award · 10b5-1 plan | A | $2,505 102 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 0 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | Derivative conversion · 10b5-1 plan | C | — 83.3K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 0 | Bernstein HaroldPresident, R&D & CMO | Option exercise · 10b5-1 plan | M | $152K 14.6K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 0 | Bernstein HaroldPresident, R&D & CMO | Option exercise · 10b5-1 plan | M | — 14.6K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 52 | Shen XiaojieDirector | Open-market purchase | BUY | $42K 2,436 sh | Jul 1, 2026 traded Jun 29, 2026 |
| 47 | Vahland WinfriedDirector | Open-market purchase | BUY | $102K 6,000 sh | Jul 1, 2026 traded Jun 29, 2026 |
| 47 | Bhalla Narinder PalChief Medical Officer | Open-market sale | SELL | $99K 22.3K sh | Jul 1, 2026 traded Jul 1, 2026 |